STAT5 Is Necessary for the Metabolic Switch Induced by IL-2 in Cervical Cancer Cell Line SiHa

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• Tumor cells reprogram metabolism to meet high energy demands for uncontrolled growth.
• Cytokines like Interleukin-2 (IL-2) activate signaling pathways, including JAK/STAT, influencing cellular processes.
• The JAK/STAT pathway's role in linking cytokine signaling to cancer cell metabolism is not fully understood.

Purpose of the Study:

• To investigate the effect of IL-2 on metabolic reprogramming in cervical cancer cells.
• To elucidate the specific role of STAT5 in IL-2-mediated metabolic changes and cell proliferation.

Main Methods:

• Analysis of IL-2's impact on cervical cancer cell proliferation and STAT5 phosphorylation.
• Measurement of lactate secretion and NAD+/NADH ratio to assess metabolic shifts.
• Gene expression analysis (HIF1α, GLUT1) following STAT5 silencing.

Main Results:

• IL-2 treatment increased cervical cancer cell proliferation, STAT5 phosphorylation, lactate secretion, and NAD+/NADH ratio.
• STAT5 silencing reduced lactate secretion, NAD+/NADH ratio, and expression of HIF1α and GLUT1.
• These findings indicate STAT5 mediates IL-2-induced aerobic glycolysis and cell proliferation.

Conclusions:

• STAT5 plays a crucial role in mediating IL-2-induced metabolic reprogramming in cervical cancer.
• STAT proteins regulate the metabolic switch to aerobic glycolysis, supporting cancer cell energy demands for growth and proliferation.
• Targeting the IL-2/STAT5 pathway could offer therapeutic strategies for cervical cancer.